pakistan
Moderna and other groups get $60 million to develop Ebola vaccine
Key takeaways
- The Coalition for Epidemic Preparedness Innovations was one of the early investors that helped to develop a vaccine at the height of the COVID-19 pandemic.
- Richard Hatchett, head of CEPI, told Reuters on Monday it was possible to get Ebola Bundibugyo (BDBV) vaccines ready for trials within a couple of months.
- There are currently no approved BDBV vaccines or treatments.
Why this matters: local context for readers following news across Pakistan and the region.
Add ARY News on Google AAResize Global health organisation CEPI will give roughly $60 million to Moderna and two other groups to accelerate the development of shots against Ebola Bundibugyo, the deadly virus that has swept through eastern Democratic Republic of Congo.
The Coalition for Epidemic Preparedness Innovations was one of the early investors that helped to develop a vaccine at the height of the COVID-19 pandemic.
Richard Hatchett, head of CEPI, told Reuters on Monday it was possible to get Ebola Bundibugyo (BDBV) vaccines ready for trials within a couple of months.
Article preview — originally published by ARY News. Full story at the source.
Read full story on ARY News →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from ARY News alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop